Apr 9, 2025 · This PDQ cancer information summary has current information about the treatment of chronic myeloid leukemia. It is meant to inform and help patients, families, and caregivers.

Most people in chronic phase CML have good responses to treatment. But even if the BCR::ABL1 gene can no longer be detected, it’s often not clear if a person is cured, so most people need to continue …

Feb 1, 2026 · For patients with chronic myeloid leukemia in chronic phase (CML-CP), disease management, treatment experiences, and decisions around switching therap…

Feb 27, 2025 · We cover combination therapy approaches to address TKI resistance in the setting of residual leukemia and in advanced CML. Despite the unprecedented success of TKIs in CML, more …

Apr 6, 2025 · This blog post provides an overview of Chronic Myeloid Leukemia (CML) and its treatment strategies based on the most recent guideline (2025) from the National Comprehensive Cancer …

1 day ago · Together, these strategies help optimize treatment effectiveness, reduce disease progression risk, and improve QoL for patients with CML. Beyond its role in response assessment …

Jul 3, 2023 · Several analyses describing real-world practice patterns show that tyrosine kinase inhibitors (TKIs) are the most commonly prescribed agents in multiple lines of therapy. First …

Jul 1, 2024 · In this review, we summarize data for each approved TKI across lines of therapy in patients with CML in chronic phase, highlighting elements of each agent’s safety and efficacy profile that may …

Nov 18, 2024 · Typically, CML has three clinical phases: an initial chronic phase, during which the disease process is easily controlled; then a transitional and unstable course (accelerated phase); and,...

Tyrosine kinase inhibitors (TKIs) are targeted therapy drugs often used as treatment for newly diagnosed patients with chronic phase CML. TKIs, such as imatinib and others, can stop the BCR …